sellWeak cluster of 410b5-1 plan
Michael Zinda sold $3,999 of RPTX
EVP, CHIEF SCIENTIFIC OFFICER at Repare Therapeutics Inc.. 860 shares at an average of $4.65, traded Mar 28, 2024, filed Apr 1, 2024.
Warning score
10Value
$3,999
860 shares
Holdings after
71,908
-1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- 0Trade size$4k at market
- 0Share of holdings soldSold 1.2% of holdings
- +15Cluster4 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-24-009625, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 28, 2024 | SOpen-market sale Common Shares10b5-1 | -450 | $4.64 | $2,088 | 72,318 | Apr 1, 2024 |
| Apr 1, 2024 | SOpen-market sale Common Shares10b5-1 | -410 | $4.66 | $1,911 | 71,908 | Apr 1, 2024 |
Related signals
Other insiders at Repare Therapeutics Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 35Weak | Repare Therapeutics Inc. | Steve Forte EVP, CHIEF FINANCIAL OFFICER | $7,848 6,884 shares | -11% | |
| 23Weak | Repare Therapeutics Inc. | Maria Koehler EVP, CHIEF MEDICAL OFFICER | $4,099 3,596 shares | -2% | |
| 17Weak | Repare Therapeutics Inc. | Steve Forte EVP, CHIEF FINANCIAL OFFICER | $7,449 1,614 shares | -3% | |
| 10Weak | Repare Therapeutics Inc. | Maria Koehler EVP, CHIEF MEDICAL OFFICER | $3,718 800 shares | -0% | |
| 20Weak | Repare Therapeutics Inc. | Lloyd Mitchell Segal PRESIDENT AND CEO | $24k 5,141 shares | -5% | |
| 17Weak | Repare Therapeutics Inc. | Steve Forte EVP, CHIEF FINANCIAL OFFICER | $12k 2,475 shares | -6% | |
| 10Weak | Repare Therapeutics Inc. | Maria Koehler EVP, CHIEF MEDICAL OFFICER | $7,000 1,500 shares | -1% | |
| 26Weak | Repare Therapeutics Inc. | Lloyd Mitchell Segal PRESIDENT AND CEO | $37k 7,950 shares | -9% | |
| 10Weak | Repare Therapeutics Inc. | Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER | $6,305 1,350 shares | -2% | |
| 43Moderate | RPTXbuy Repare Therapeutics Inc. | Bvf Partners L P/il owner | $6.2M 1,227,301 shares | +26% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.